Bone Marrow Failure
📧 Sign up to get email alerts when something new happens for Bone Marrow Failure.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-12-03Clinical Trial Update: The Use of Eltrombopag Post HSCT in BMFD [Phase 2, Phase 3]
A Phase 2/3 clinical trial evaluating eltrombopag after hematopoietic stem cell transplantation for bone marrow failure has completed.
-
CLINICAL_TRIALS trial_result · 2025-04-13Clinical Trial Update: A Clinical Trial of CK0801 (a New Drug) in Patients With Bone Marrow Failure Syndrome (BMF) [Phase 1]
Phase 1 clinical trial update for CK0801 in patients with bone marrow failure; the study is currently active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2024-10-31Clinical Trial Update: Risk-Adapted Allogeneic Stem Cell Transplantation For Mixed Donor Chimerism In Patients With Non-Malignant Diseases [Phase 2, Phase 3]
Clinical trial update reports Phase 2 and Phase 3 results for risk-adapted allogeneic stem cell transplantation in non-malignant diseases wi…
-
CLINICAL_TRIALS trial_result · 2024-07-30Clinical Trial Update: TPO-Mimetic Use in Children for Hematopoietic Failure [EARLY_Phase 1]
An early-phase 1 pediatric trial evaluating thrombopoietin mimetics for hematopoietic failure has completed. The study enrolled children wit…
-
CLINICAL_TRIALS trial_result · 2019-10-22Clinical Trial Update: CD34+ Stem Cell Infusion to Augment Graft Function [Phase 2]
Phase 2 trial investigating CD34+ stem cell infusion to augment graft function; the study was terminated with results posted in 2019.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-08-21Clinical Trial Update: CD34+Selection for Partially Matched Family or Matched Unrelated Adult Donor Transplant [Phase 2]
Phase 2 clinical trial update on CD34+ selection for partially matched family or matched unrelated adult donor transplants in leukemia and l…
-
CLINICAL_TRIALS trial_result · 2013-08-12Clinical Trial Update: Alemtuzumab and Low-Dose Cyclosporine in Treating Patients With Severe Aplastic Anemia or Acquired Marrow Failure [Phase 2]
Phase 2 clinical trial update evaluating alemtuzumab with low-dose cyclosporine in patients with severe aplastic anemia or acquired marrow f…
-
CLINICAL_TRIALS trial_result · 2013-01-03Clinical Trial Update: Safety and Efficacy of Levamisole Combined With Cyclosporine A in Patients With Subclinical Paroxysmal Nocturnal Hemoglobinuria and PNH in the Setting of Another Bone Marrow Failure Syndromes(PNH-2013) [Phase 2]
Phase 2 trial evaluating the safety and efficacy of combining levamisole with cyclosporine A in patients with paroxysmal nocturnal hemoglobi…